IN189723B - - Google Patents

Info

Publication number
IN189723B
IN189723B IN1698DE1998A IN189723B IN 189723 B IN189723 B IN 189723B IN 1698DE1998 A IN1698DE1998 A IN 1698DE1998A IN 189723 B IN189723 B IN 189723B
Authority
IN
India
Application number
Other languages
English (en)
Inventor
Stephen Alistair Smith
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of IN189723B publication Critical patent/IN189723B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin

Landscapes

  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Plural Heterocyclic Compounds (AREA)
IN1698DE1998 1997-06-18 1998-06-18 IN189723B (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9712866.4A GB9712866D0 (en) 1997-06-18 1997-06-18 Novel method of treatment

Publications (1)

Publication Number Publication Date
IN189723B true IN189723B (zh) 2003-04-19

Family

ID=10814527

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1698DE1998 IN189723B (zh) 1997-06-18 1998-06-18

Country Status (30)

Country Link
EP (1) EP0999837A1 (zh)
JP (1) JP2002504138A (zh)
KR (1) KR20010013843A (zh)
CN (1) CN1133431C (zh)
AP (1) AP1287A (zh)
AR (2) AR012997A1 (zh)
AU (1) AU8216398A (zh)
BG (1) BG104059A (zh)
BR (1) BR9810444A (zh)
CA (1) CA2294141A1 (zh)
CO (1) CO4940454A1 (zh)
DZ (1) DZ2521A1 (zh)
EA (1) EA004800B1 (zh)
GB (1) GB9712866D0 (zh)
HU (1) HUP0003260A3 (zh)
ID (1) ID23951A (zh)
IL (1) IL133143A0 (zh)
IN (1) IN189723B (zh)
MA (1) MA26511A1 (zh)
NO (1) NO996265D0 (zh)
OA (1) OA11517A (zh)
PE (1) PE104499A1 (zh)
PL (1) PL343123A1 (zh)
SK (1) SK179399A3 (zh)
TR (1) TR199903095T2 (zh)
TW (1) TW587937B (zh)
UA (1) UA70299C2 (zh)
UY (1) UY25050A1 (zh)
WO (1) WO1998057636A1 (zh)
ZA (1) ZA985237B (zh)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6291495B1 (en) * 1997-02-24 2001-09-18 Robert B. Rieveley Method and composition for the treatment of diabetes
TWI249401B (en) 1999-04-14 2006-02-21 Takeda Chemical Industries Ltd Agent for improving ketosis
OA11871A (en) 1999-04-23 2006-03-27 Smithkline Beecham Plc Novel pharmaceutical.
AU5325200A (en) 1999-06-21 2001-01-09 Eli Lilly And Company Synergistic use of thiazolidinediones with glucagon-like peptide-1 and agonists thereof to treat metabolic instability associated with non-insulin dependent diabetes
EP1196189A2 (en) 1999-06-25 2002-04-17 Medtronic MiniMed, Inc. Multiple agent diabetes therapy
US6468507B1 (en) * 2000-05-01 2002-10-22 Aeropharm Technology, Inc. Non-aqueous aerosol formulation comprising rosiglitazone maleate, a non-aqueous carrier, and an amino acid stabilizer
GB0023970D0 (en) * 2000-09-29 2000-11-15 Smithkline Beecham Plc Novel pharmaceutical
WO2002067969A2 (en) 2001-02-21 2002-09-06 Medtronic Minimed, Inc. Stabilized insulin formulations
US6531461B1 (en) 2001-06-04 2003-03-11 Louis Obyo Obyo Nelson Medicament for the treatment of diabetes
WO2002100396A1 (en) * 2001-06-07 2002-12-19 Wyeth COMBINATION OF A PTPase INHIBITOR AND A THIAZOLIDINEDIONE AGENT
US6737401B2 (en) 2001-06-28 2004-05-18 Metronic Minimed, Inc. Methods of evaluating protein formulation stability and surfactant-stabilized insulin formulations derived therefrom
KR100699614B1 (ko) 2002-11-08 2007-03-23 에프. 호프만-라 로슈 아게 퍼옥시좀 증식자 활성화된 수용체 작용제로서의 치환된4-알콕시옥사졸 유도체
US7264813B2 (en) 2003-09-24 2007-09-04 Nikken Sohonsha Corporation Therapeutic uses of Dunaliella powder
CN102389427A (zh) * 2011-10-10 2012-03-28 成都恒瑞制药有限公司 含有罗格列酮和盐酸西替利嗪的固体口服制剂

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU228260B1 (en) * 1993-09-15 2013-02-28 Daiichi Sankyo Company Pharmaceutical compositions to treat impaired glucose tolerance
NZ313874A (en) * 1995-08-10 2000-09-29 Warner Lambert Co Compounds used as medicaments useful in eliminating the amount of exogenous insulin administered to a patient having noninsulin-dependent diabetes mellitus
EP0859608B1 (en) * 1995-09-18 2004-02-11 Ligand Pharmaceuticals, Inc. Treating niddm with rxr agonists

Also Published As

Publication number Publication date
CO4940454A1 (es) 2000-07-24
NO996265L (no) 1999-12-17
CA2294141A1 (en) 1998-12-23
AP9901718A0 (en) 1999-12-31
ZA985237B (en) 2000-02-17
OA11517A (en) 2004-02-04
MA26511A1 (fr) 2004-12-20
UY25050A1 (es) 2000-09-29
EA004800B1 (ru) 2004-08-26
DZ2521A1 (fr) 2003-02-08
EP0999837A1 (en) 2000-05-17
ID23951A (id) 2000-06-08
AR012997A1 (es) 2000-11-22
TW587937B (en) 2004-05-21
KR20010013843A (ko) 2001-02-26
WO1998057636A1 (en) 1998-12-23
UA70299C2 (en) 2004-10-15
PE104499A1 (es) 2000-01-13
SK179399A3 (en) 2000-11-07
NO996265D0 (no) 1999-12-17
EA200000042A1 (ru) 2000-08-28
JP2002504138A (ja) 2002-02-05
HUP0003260A2 (hu) 2001-05-28
TR199903095T2 (xx) 2000-08-21
GB9712866D0 (en) 1997-08-20
IL133143A0 (en) 2001-03-19
AP1287A (en) 2004-06-26
BG104059A (en) 2000-10-31
CN1260715A (zh) 2000-07-19
AR015894A1 (es) 2001-05-30
HUP0003260A3 (en) 2001-12-28
AU8216398A (en) 1999-01-04
BR9810444A (pt) 2000-09-05
PL343123A1 (en) 2001-07-30
CN1133431C (zh) 2004-01-07

Similar Documents

Publication Publication Date Title
BE2018C032I2 (zh)
IN188777B (zh)
CH0944937H2 (zh)
IN189275B (zh)
IN189723B (zh)
IN189367B (zh)
BE2013C047I2 (zh)
ITPS970022V0 (zh)
ITTV970023V0 (zh)
ITGE970030A0 (zh)
IN186458B (zh)
IN191985B (zh)
BR9701757A (zh)
BR9700653A (zh)
CN3054902S (zh)
CN3058000S (zh)
BY4238C1 (zh)
CN3057614S (zh)
CN3057613S (zh)
BY4349C1 (zh)
CN3054556S (zh)
CN3053170S (zh)
CN3057730S (zh)
CN3057976S (zh)
CN3057436S (zh)